Tag: gut health

The clinical landscape of primary hyperparathyroidism (PHPT) has long been defined by a clear therapeutic gold standard: surgical intervention. However, a recent case study published in JCEM Case Reports by Sara Ramadan, MD, and her mentor Shirin Haddady, MD, MPH, has introduced a compelling anomaly into the medical literature. The study, titled “Unanticipated remission of…

On July 15, a coalition of leading healthcare organizations, including the American College of Obstetricians and Gynecologists (ACOG), the Society for Women’s Health Research (SWHR), and the Women First Research Coalition (WFRC), formally introduced the National Strategy to Close the Women’s Health Gap. This comprehensive policy framework issues a direct call to the United States…

The Endocrine Society’s Excellence in Clinical Endocrinology Leadership (EXCEL) program recently convened its latest session at the society’s headquarters in Washington, D.C., bringing together a diverse cohort of practitioners, researchers, and emerging leaders. This gathering served as more than a standard professional development seminar; it acted as a forum for deep reflection on the shifting…

The global endocrine community gathered in Chicago for ENDO 2026, the annual meeting of the Endocrine Society, where several biotechnology and pharmaceutical leaders unveiled pivotal data that could redefine treatment standards for rare hormonal disorders. From advancements in congenital adrenal hyperplasia (CAH) and Cushing’s syndrome to novel therapies for acromegaly and hyperinsulinism, the week was…

The American Academy of Arts and Sciences (AAAS) has officially announced the election of Joseph T. Bass, MD, PhD, to its prestigious ranks, recognizing his transformative contributions to the fields of endocrinology and circadian biology. Dr. Bass, who serves as the Charles F. Kettering Professor of Medicine and Chief of the Division of Endocrinology, Metabolism,…

The landscape of endocrine medicine has shifted significantly this week following a series of regulatory milestones and clinical trial successes that promise to reshape the treatment paradigms for both pediatric diabetes and rare adrenal disorders. Leading the headlines is the U.S. Food and Drug Administration’s (FDA) decision to expand the use of Sanofi’s Tzield (teplizumab-mzwv)…

In a significant development for the field of neuroendocrinology, Daniel Hochbaum, MD, an assistant professor in the Program in Neuroscience at Harvard Medical School and Beth Israel Deaconess Medical Center, has been named a recipient of the Pershing Square Foundation’s Maximizing Innovation in Neuroscience Discovery (MIND) Prize. This accolade includes a $750,000 grant distributed over…

The medical community is witnessing a fundamental transformation in the management of obesity and metabolic syndrome, shifting away from treating isolated complications toward addressing the root cause of adiposity. At a recent virtual Science Writers Conference hosted by the Endocrine Society, leading experts gathered to discuss the rapidly advancing landscape of glucagon-like peptide-1 receptor agonists…

A groundbreaking study published in the Journal of the Endocrine Society has revealed that a father’s exposure to nicotine can have profound, multi-generational effects on the metabolic health of his offspring. The research, conducted by a team at the University of California, Santa Cruz (UCSC), suggests that nicotine consumption—even in the absence of the thousands…

The Endocrine Society has officially announced that Rebecca Reynolds, MD, PhD, a distinguished physician-scientist at the University of Edinburgh, has been selected as the recipient of the 2026 International Excellence in Endocrinology Laureate Award. This prestigious recognition, part of the Society’s annual Laureate Awards program, celebrates individuals who have made exceptional contributions to the field…